206 related articles for article (PubMed ID: 34339733)
1. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly.
Weismiller HA; Holub TJ; Krzesinski BJ; Margittai M
J Biol Chem; 2021 Sep; 297(3):101021. PubMed ID: 34339733
[TBL] [Abstract][Full Text] [Related]
2. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
3. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
4. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
5. MAP2 caps tau fibrils and inhibits aggregation.
Holden MR; Krzesinski BJ; Weismiller HA; Shady JR; Margittai M
J Biol Chem; 2023 Jul; 299(7):104891. PubMed ID: 37286038
[TBL] [Abstract][Full Text] [Related]
6. Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer.
Jebarupa B; Mathew B; Srinivasu BY; Sasikumaran A; Joseph S; Mandal AK; Thomas T; Mitra G
Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):993-1005. PubMed ID: 30853336
[TBL] [Abstract][Full Text] [Related]
7. Precision proteoform design for 4R tau isoform selective templated aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger MT; Sclafani OR; Fu V; Beckett ER; Vigers M; Buée L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320456121. PubMed ID: 38568974
[TBL] [Abstract][Full Text] [Related]
8. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
9. Using intramolecular disulfide bonds in tau protein to deduce structural features of aggregation-resistant conformations.
Walker S; Ullman O; Stultz CM
J Biol Chem; 2012 Mar; 287(12):9591-600. PubMed ID: 22291015
[TBL] [Abstract][Full Text] [Related]
10. Cofactors are essential constituents of stable and seeding-active tau fibrils.
Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13234-13239. PubMed ID: 30538196
[TBL] [Abstract][Full Text] [Related]
11. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
[TBL] [Abstract][Full Text] [Related]
12. Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau.
Siddiqua A; Luo Y; Meyer V; Swanson MA; Yu X; Wei G; Zheng J; Eaton GR; Ma B; Nussinov R; Eaton SS; Margittai M
J Am Chem Soc; 2012 Jun; 134(24):10271-8. PubMed ID: 22656332
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R.
Kumar H; Udgaonkar JB
J Mol Biol; 2018 Dec; 430(24):5304-5312. PubMed ID: 30267747
[TBL] [Abstract][Full Text] [Related]
14. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
Kraus A; Saijo E; Metrick MA; Newell K; Sigurdson CJ; Zanusso G; Ghetti B; Caughey B
Acta Neuropathol; 2019 Apr; 137(4):585-598. PubMed ID: 30570675
[TBL] [Abstract][Full Text] [Related]
15. Trans-seeding of Alzheimer-related tau protein by a yeast prion.
Flach M; Leu C; Martinisi A; Skachokova Z; Frank S; Tolnay M; Stahlberg H; Winkler DT
Alzheimers Dement; 2022 Dec; 18(12):2481-2492. PubMed ID: 35142027
[TBL] [Abstract][Full Text] [Related]
16. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement.
Vigers MP; Lobo S; Najafi S; Dubose A; Tsay K; Ganguly P; Longhini AP; Jin Y; Buratto SK; Kosik KS; Shell MS; Shea JE; Han S
bioRxiv; 2023 Nov; ():. PubMed ID: 38077065
[TBL] [Abstract][Full Text] [Related]
17. The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity
Prifti E; Tsakiri EN; Vourkou E; Stamatakis G; Samiotaki M; Papanikolopoulou K
J Neurosci; 2021 Jan; 41(4):797-810. PubMed ID: 33334867
[TBL] [Abstract][Full Text] [Related]
18. Single mutations in tau modulate the populations of fibril conformers through seed selection.
Meyer V; Dinkel PD; Luo Y; Yu X; Wei G; Zheng J; Eaton GR; Ma B; Nussinov R; Eaton SS; Margittai M
Angew Chem Int Ed Engl; 2014 Feb; 53(6):1590-3. PubMed ID: 24453187
[TBL] [Abstract][Full Text] [Related]
19. Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation.
Crowe A; James MJ; Lee VM; Smith AB; Trojanowski JQ; Ballatore C; Brunden KR
J Biol Chem; 2013 Apr; 288(16):11024-37. PubMed ID: 23443659
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.
Abskharon R; Seidler PM; Sawaya MR; Cascio D; Yang TP; Philipp S; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Felgner PL; Nakajima R; Glabe CG; Eisenberg DS
J Biol Chem; 2020 Jul; 295(31):10662-10676. PubMed ID: 32493775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
